BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gerosa M, Chighizola C, Meroni PL. Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases). Intern Emerg Med 2008;3:201-3. [DOI: 10.1007/s11739-008-0170-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bazzan M, Vaccarino A. Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients. Intern Emerg Med 2009;4:61-2. [PMID: 19082904 DOI: 10.1007/s11739-008-0209-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Lu C, Liu Y, Jiang H. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials. The Journal of Maternal-Fetal & Neonatal Medicine 2019;32:1299-311. [DOI: 10.1080/14767058.2017.1404979] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
3 Tincani A, Andreoli L, Chighizola C, Meroni PL, Tincani A, Andreoli L, Chighizola C, Meroni PL. The interplay between the antiphospholipid syndrome and systemic lupus erythematosus. Autoimmunity 2009;42:257-9. [DOI: 10.1080/08916930902827918] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
4 Galli M. Aspirin thromboprophylaxis of asymptomatic antiphospholipid-positive subjects. Intern Emerg Med 2009;4:63-4. [DOI: 10.1007/s11739-008-0203-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Qushmaq NA, Al-Emadi SA. Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety. ISRN Rheumatol 2014;2014:348726. [PMID: 24944829 DOI: 10.1155/2014/348726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
6 Andreoli L, Tincani A. 25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. Intern Emerg Med 2009;4:165-7. [DOI: 10.1007/s11739-008-0222-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Espinosa G, Cervera R. Thromboprophylaxis and obstetric management of the antiphospholipid syndrome. Expert Opinion on Pharmacotherapy 2009;10:601-14. [DOI: 10.1517/14656560902772302] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
8 Basili S, Violi F. Aspirin in asymptomatic patients with a confirmed positivity of antiphospholipid antibodies. Intern Emerg Med 2008;3:373-4. [DOI: 10.1007/s11739-008-0193-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Espinosa G, Cervera R. Management of the antiphospholipid syndrome. Auto Immun Highlights 2010;1:15-22. [PMID: 26000103 DOI: 10.1007/s13317-010-0004-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Espinosa G, Cervera R. Antiphospholipid syndrome. Arthritis Res Ther 2008;10:230. [PMID: 19090981 DOI: 10.1186/ar2536] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
11 Bettiol A, Emmi G, Finocchi M, Silvestri E, Urban ML, Mattioli I, Scalera A, Lupoli R, Vannacci A, Di Minno MND, Prisco D. Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. Rheumatology 2020;59:3709-16. [DOI: 10.1093/rheumatology/keaa116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tufano A, Guida A, Di Minno M, De Gregorio A, Cerbone A, Di Minno G. Cardiovascular events in patients with antiphospholipid antibodies: Strategies of prevention. Nutrition, Metabolism and Cardiovascular Diseases 2010;20:217-23. [DOI: 10.1016/j.numecd.2009.10.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
13 Giles I, Rahman A. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive. Best Practice & Research Clinical Rheumatology 2009;23:525-37. [DOI: 10.1016/j.berh.2009.01.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
14 Chighizola CB, Ubiali T, Meroni PL. Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches. J Immunol Res 2015;2015:951424. [PMID: 26075289 DOI: 10.1155/2015/951424] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]